Detwiler R K, Singh H K, Bolin P, Jennette J C
Department of Pathology, East Carolina University School of Medicine, Greenville, NC 27858, USA.
Am J Kidney Dis. 1998 Nov;32(5):820-4. doi: 10.1016/s0272-6386(98)70139-8.
A 35-year-old black man with end-stage renal disease from biopsy-proven focal segmental glomerulosclerosis developed worsening function of his renal allograft 160 days after living related donor renal transplantation. Renal biopsy showed necrotizing and crescentic glomerulonephritis (NCGN) and presence of intraglomerular viral inclusions confirmed by immunocytochemical stain and in situ hybridization techniques to be cytomegaloviral in origin. Electron microscopy showed no immune complexes, and workup for other causes of NCGN was negative. The patient was treated with ganciclovir without other changes in his immunosuppressive regimen. After 8 weeks of ganciclovir therapy, a second renal transplant biopsy showed resolution of the glomerular process and disappearance of the cytomegalovirus (CMV) inclusions. The resolution of the glomerular process with treatment for CMV infection, and without other change in therapy, strongly supports a causative link between CMV and NCGN in this patient. This case represents the first report of CMV-associated NCGN in a renal transplant patient.
一名35岁的黑人男性,患有活检证实的局灶节段性肾小球硬化所致的终末期肾病,在活体亲属供肾肾移植术后160天,其移植肾功能恶化。肾活检显示坏死性和新月体性肾小球肾炎(NCGN),免疫细胞化学染色和原位杂交技术证实肾小球内存在病毒包涵体,其来源为巨细胞病毒。电子显微镜检查未发现免疫复合物,对NCGN的其他病因检查结果为阴性。患者接受了更昔洛韦治疗,免疫抑制方案未作其他改变。更昔洛韦治疗8周后,第二次肾移植活检显示肾小球病变消退,巨细胞病毒(CMV)包涵体消失。经CMV感染治疗后肾小球病变消退,且治疗无其他改变,有力地支持了该患者CMV与NCGN之间的因果关系。该病例是肾移植患者中CMV相关性NCGN的首例报告。